Yaldoo Laith L's Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Apr 4, 2025
- Accession no.
- 0001654954-25-003907
- Filed
- Apr 4, 2025
- Trade date
- Jan 22, 2025
- Filing delay
- 72 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $176.7K. It was filed 72 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yaldoo Laith LCIK 0001641073 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | Common Stock | PPurchaseAcquired | +7,200 | $17.53 | +$126,216 | 551,746 | Indirect | |
| Jan 22, 2025 | Common Stock | PPurchaseAcquired | +2,880 | $17.53 | +$50,486.4 | 554,626 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.